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Highlights 
 DHA supplementation is examined in rats during pregnancy with a background diet that 
resembles human Western diets and a standard rodent chow. 
 DHA concentrations are lower in maternal adipose during pregnancy and postpartum in 
the Western diet without DHA. 
 At postpartum DHA concentrations decrease below baseline levels in maternal heart and 
liver of the dams fed Western diets without DHA and in liver in the chow diet. 
 Low maternal DHA intakes was associated with lower DHA concentrations in the 7d old 
pups but not the fetuses  
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Abstract 
Fetal accretion for DHA is high during late pregnancy due to the brain growth spurt.  Prior 
evidence suggests that DHA is mobilized from maternal liver and adipose to meet fetal accretion 
and physiological requirements. However, changes in the DHA levels of various maternal tissues 
throughout pregnancy and into lactation of mothers on diets with and without dietary DHA, and 
with a background dietary fatty acid profile that resembles human intake has not been examined. 
Sprague Dawley rats were fed a total western diet with (TWD+) or without DHA (TWD-) along 
with a commercial rodent chow control (Chow) throughout pregnancy and postpartum.  The fatty 
acid compositions of adipose, brain, heart, liver, erythrocytes, and plasma were determined 
before pregnancy, at 15 and 20 days of pregnancy, and 7 days postpartum.  The placenta, fetuses, 
and pups were also examined when available.  Maternal DHA concentrations were increased in 
plasma at 20 days pregnancy in all the diets with TWD+>Chow>TWD-.  Maternal DHA 
concentrations in the TWD- group were lower in adipose throughout pregnancy as compared 
with the other diets.  At postpartum, DHA concentrations decreased below baseline levels in the 
heart of the TWD- and Chow dams and the liver of the TWD- dams. Whole body DHA 
concentrations of the fetuses did not differ but there was evidence of decreased DHA in the 
whole body and tissues of the TWD- and Chow 7d old pups.  In conclusion, it appears that in this 
rodent model of pregnancy, maternal adaptations were made to meet fetal DHA requirements, 
but they may compromise maternal DHA status and the ability to deliver DHA during lactation. 
 
Keywords 
Docosahexaenoic acid, omega-3, pregnancy, lactation, postpartum, heart, plasma, fetus, pup, 
infant, fatty acid composition 
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Abbreviations 
ALA, alpha-linolenic acid; ARA: arachidonic acid; LA, linoleic acid; EPA, eicosapentaenoic 
acid; DPA, docosapentaenoic acid; DHA, docosahexaenoic acid; LC, long chain; SFA, saturated 
fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid; BHT, 
Butylated hydroxytoluene.   
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1. Introduction 
Docosahexaenoic acid (DHA) has been shown to be essential for neurodevelopment and 
infant health [1, 2]. Levels of DHA in plasma increase approaching parturition in both humans 
[3-5] and rats [6, 7], likely as an adaptation to meet fetal accretion during fetal brain growth. 
Mechanisms responsible for this increase have not been fully identified, but dietary intake, 
upregulated de novo synthesis and mobilization from maternal tissues are potential mechanisms 
[2, 6, 8-10]. Maternal intake of DHA during pregnancy is low in North America [11], therefore 
fetal DHA requirements for accretion likely exceeds maternal DHA intakes near parturition [12] 
for a considerable proportion of the population. Although de novo synthesis of DHA appears to 
be upregulated during pregnancy [8], the rate of DHA conversion from alpha-linolenic acid 
(ALA) in adults is generally considered to be less than 1% [13]. Evidence suggests DHA is 
mobilized from maternal liver and adipose depots during pregnancy and lactation [9, 10, 14, 15].  
It is possible that DHA could also be mobilized from other maternal tissues, particularly those 
demonstrated to be rich in DHA [16] to help meet fetal and infant tissue accretion requirements.  
General lipid mobilization from maternal tissues during pregnancy and lactation could 
assist in providing a stable and constant supply of fatty acids and prevent diurnal and dietary 
intake-based fluctuations that impact fetal and infant development. Dependency on dietary intake 
would be subject to postprandial fluctuations in lipid circulation [17], and considerable variation 
in the fatty acid composition of individual meals.  DHA intake by humans can be quite sporadic, 
especially in Western populations [18, 19].  While de novo biosynthesis from ALA could provide 
a stable supply of DHA, high dietary intakes of n-6 polyunsaturated fatty acids (PUFA) [20] and 
monounsaturated fatty acids (MUFA) [21] in most human diets [22, 23] could limit hepatic 
elongation and desaturation rates.  Therefore, mobilization of DHA that has been accrued in 
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maternal tissues over time could be an adaptation to ensure that the fetus and infant have a stable 
supply of a minimal amount of DHA during critical periods of development regardless of dietary 
intake during pregnancy.  Balance studies of rats fed diets without eicosapentaenoic acid (EPA) 
and DHA show a net loss of DHA in adipose during pregnancy [15, 24]. Maternal DHA status 
has also been linked to DHA levels in breast milk, and mobilization of DHA from maternal 
stores may be critical to support lactation [25]. 
DHA may be mobilized from various maternal tissues in addition to adipose during 
pregnancy and postpartum. We hypothesized that DHA in different maternal tissues will change 
differently during pregnancy, and that these changes would be influenced by maternal dietary 
DHA intakes.  This was examined with a background rodent diet designed to emulate a typical 
human Western diet, including percentages of saturated fatty acids (SFA), MUFA and PUFA 
[26] and compared to a common rodent chow diet as an additional reference control. Maternal 
liver, brain, adipose, heart, erythrocytes, and plasma, as well as placenta, and fetal and pup 
tissues were examined throughout pregnancy and into the postpartum period across all diets.   
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2. Materials and methods 
2.1 Study design 
All animal experiments were performed in agreement with the policies of the Canadian 
Council on Animal Care and approved by the University of Waterloo Animal Care Committee. 
Female Sprague-Dawley rats (7 weeks of age) and diets were purchased from Envigo 
(Mississauga, Ontario, Canada).  Baseline rats were not bred and fed either a fixed-formula 8640 
Teklad 22/5 Rodent Diet (Chow), a TD.110424 total western diet without DHA (TWD-), or the 
total western diet with DHA added (TWD+) (Table 1) for 7 days prior to being sacrificed (n=6 
per diet).   The chow diet was a natural-ingredient diet consisting of dehulled soybean meal, 
ground corn, wheat middlings, flaked corn, fish meal, cane molasses, soybean oil, ground wheat, 
and dried whey with additional vitamins and minerals. The formulation of the TWD was 
designed to mimic the dietary intake of Americans rather than rodent growth and fertility [26].  
Briefly, it has more energy from fat (Supplemental Table 1) and composed of purified 
ingredients with protein from casein with additional cystine, carbohydrates from corn starch, 
maltodextrin and sucrose, and fat from a mixture of olive oil, soybean oil, corn oil, lard, beef 
tallow and milkfat.  The TWD diet is also lower in micronutrient content with the exception of 
sodium and other phytochemicals such as isoflavones were likely lower in the TWD diet due to 
the use of purified ingredients, but these differences were not confirmed biochemically.  In the 
TWD+ diet, 4.85 g/kg of DHASCO (DSM Nutritional Products Inc., Columbia, MD, USA) 
replaced a proportion of the fat mixture to achieve a DHA composition of 1.21% total fatty acids 
to mimic levels consumed by Japanese women [27].  
Rats assigned to the pregnancy groups were housed with male breeders and fed chow 
diets until confirmation of pregnancy by vaginal plug. Upon confirmation of pregnancy, female 
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rats were immediately assigned to chow, TWD+, or TWD- diets for the remainder of the 
experiment. Following an overnight fast, rats were sacrificed at day 15 of pregnancy, day 20 of 
pregnancy, or 7 days postpartum (Fig. 1) by exsanguination after anesthesia using isoflurane 
(n=6 per group).  Food intake and body weight were measured at baseline, day 15 and 20 of 
pregnancy, and postpartum. Exsanguinated blood was collected in the presence of EDTA and 
plasma was isolated by centrifugation at 1,500 g and 4°C. Brain, liver, heart, white adipose 
(perirenal), and placenta were excised, washed in saline (0.9% v/v), weighed, and flash-frozen in 
liquid nitrogen. Fetuses were sacrificed by decapitation, washed in saline, weighed, and snap 
frozen in liquid nitrogen. Pups sacrificed by exsanguination following anesthesia using 
isoflurane were used to collect heart, brain, and liver or preserved for whole body analyses. After 
collection, samples were stored at -80°C until analysis.  
2.2 Fatty acid analyses 
The lipids from pulverized tissue samples and plasma were extracted using 2:1 
chloroform:methanol [28] containing 50μg/mL 2,6-di-tert-butyl-4-methylphenol (butylated 
hydroxytoluene, BHT; Sigma-Aldrich, St. Louis, MO, USA) and 10μg of docosatrienoic acid 
(22:3n-3, Nu Chek Prep Inc., Elysian, MN) as internal standard.  Aqueous and organic phases 
were separated by the addition of 0.2M sodium phosphate buffer, and the organic layer was 
collected.  Erythrocyte lipids were isolated using similar reagents but with a double extraction 
protocol [29]. The collected organic phases were dried under nitrogen and fatty acid methyl 
esters were generated with the addition of 1mL of 14% boron trifluoride in methanol and 0.3mL 
hexane, and heating on a heating block at 95°C for 1h [30]. Fatty acid methyl esters were then 
washed in 1mL hexane and 1mL water and the hexane layer was collected for analysis by gas 
chromatography with flame ionization detection.  Briefly, a fast gas chromatography protocol 
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[31] was followed using a Varian 3900 gas chromatograph equipped with a DB-FFAP 15m x 
0.10mm internal diameter x 0.10μm film thickness nitroterephthalic acid-modified polyethylene 
glycol capillary column (J&W Scientific/ Agilent Technologies, Mississauga, Ontario, Canada). 
Hydrogen was used as the carrier gas and temperature ramping was designed to maximize peak 
resolution [32] with 1μL samples injected at a 100:1 split ratio.  Individual fatty acid peaks were 
identified by comparison to a reference mixture of fatty acids (GLC-462; Nu-Chek Prep Inc.). 
2.3 Statistical analyses 
All statistical analyses were performed using SPSS release 20.0 (IBM, Chicago, IL, 
USA). The effect of diet and time was examined across maternal parameters using a two-way 
ANOVA with interactions.  Differences in pup tissues across diets were examined by one-way 
ANOVA.  Individual means were compared by Tukey post hoc testing after significant F-value 
by ANOVA. All data are presented as means ± SD with significance accepted when p < 0.05. 
3. Results 
3.1 Maternal food intake and body weight 
Energy intakes did not differ across the diets despite the higher energy density of the 
TWD+ and TWD- as compared with chow.  Although there was evidence of increased 
consumption by the chow group throughout, the mass intake by the chow dams was only 
significantly higher at 7 days postpartum (47.5 ± 4.37g) as compared with TWD+ dams (34.0 ± 
10.0g) and TWD- dams (32.33 ± 12.45g).  This coincided with a significant increase in maternal 
energy intakes in all diets at 7 days postpartum as compared with baseline and gestation across 
all diets (Fig. 2). Maternal body weight increased from baseline throughout pregnancy with a 
decrease at postpartum that remained higher than baseline. This was in agreement with previous 
reports using this pregnant rat model [6]. Maternal and fetal body masses did not differ between 
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diets (data not shown).  However, the body mass of 7 day old pups from TWD+ dams (14.16 ± 
2.99g) and TWD- dams (14.14 ± 2.63g) were significantly higher than those from chow dams 
(12.63 ± 1.68g).   
3.2 Fatty acid composition of maternal tissues 
The TWD+ diet supported increased concentrations of DHA in most maternal tissues 
during pregnancy while the TWD- and chow diets did not, although the responses of each tissue 
were not similar (Fig.3).  In plasma, there was a significant increase in DHA at day 20 of 
pregnancy in all three diets, and the DHA concentration with TWD+ feeding was 53% and 78% 
higher than the DHA concentrations with chow and TWD- feeding, respectively (Fig. 3A).  
These concentrations returned to baseline levels by 7 days postpartum in all the diets.  These 
increases reflected, in part, a general increase in total fatty acids in plasma at 20 days of 
pregnancy. However, the relative percentage of DHA was significantly higher at 20 days of 
pregnancy for the TWD+ and chow groups, but not the TWD- diet (Supplemental Table 2).  The 
TWD+ and TWD- diets also resulted in higher percentages of saturated and monounsaturated 
and lower percentages of n-6 polyunsaturated fatty acids as compared with plasma from the 
chow diet. Arachidonic acid (ARA) concentrations in plasma at day 20 of pregnancy did not 
differ from baseline (data not shown), but the percentages were decreased at day 20 of pregnancy 
in all diets and remained low in TWD+ and TWD- (Supplemental Table 2)  In erythrocytes, the 
increase in DHA concentrations at day 20 was also observed in all the diets, but the increase was 
more gradual, and very subtle in the chow and TWD-, and extended into postpartum for the 
TWD+ group (Fig 3 B).  In contrast to plasma, the total fatty acid concentrations of erythrocytes 
did not increase at day 20 of pregnancy.  The concentration of ARA in erythrocytes was 
decreased with chow at day 20 of pregnancy and 7 days postpartum. The percentage of ARA 
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tended to decrease in late pregnancy and the postpartum of all diets, with the TWD- diet having a 
slightly higher percentage of ARA at these time points (Supplemental Table 3). 
Liver DHA concentrations increased above baseline at day 15 and 20 in the TWD+ group 
and decreased below baseline at 7 days postpartum in the TWD- group (Fig. 3C). The relative 
percentage of DHA was significantly higher at day 20 in both the chow (6.42±0.78
 
vs 
10.96±2.98) and TWD+ groups (7.42±0.90 vs 11.35±2.45, Supplemental Table 4).  In the TWD+ 
and TWD- groups, total fatty acid concentrations significantly increased at 7 days postpartum as 
compared with day 20 of pregnancy (1.7 – 1.9 fold) and were significantly higher than chow at 7 
days postpartum (2.5 – 2.7 fold, Supplemental Table 4). These increases in liver total fatty acids 
were driven by very large increases in 16:0 and 18:1n-9, as percentages of n-3 and n-6 PUFA 
decreased in the TWD+ and TWD- diets.  Liver ARA concentrations did not change from 
baseline except for a decrease at day 20 in the chow dams (data not shown).  The percentage of 
hepatic ARA tended to be higher in the chow diet with decreased percentages at 7 days 
postpartum in the TWD diets.  
Adipose DHA concentrations were decreased throughout pregnancy in the TWD- group 
(Fig 3D).  The TWD+ and chow groups had similarly higher DHA concentrations in adipose 
throughout pregnancy and postpartum with an increase at day 20 of pregnancy that was above 
baseline levels.  There was a tendency for total fatty acid concentrations of adipose to increase 
during pregnancy and then decrease postpartum across all diets with the decrease at postpartum 
in the chow diet being the largest (Supplemental Table 5).  ARA concentrations (data not shown) 
and percentages decreased in both TWD diets from baseline to postpartum with no differences in 
the chow rats.  In the heart, DHA concentrations increased in the TWD+ at day 20 of pregnancy 
and then returned to baseline levels (Fig 3E).  In the TWD- and chow groups, heart DHA 
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concentrations did not increase at day 20 and significantly decreased at 7 days postpartum (Fig 
3E) and there was evidence of increased percentages of 22:4n-6 and 22:5n-6 in these groups as 
compared with the TWD+ group (Supplemental Table 6).  The concentrations and percentages of 
ARA in heart tended to be increased above baseline at day 20 of pregnancy in all diets with 
TWD- concentrations and percentages tending to be higher than the other diets.  Maternal brain 
DHA concentrations in the TWD- group were significantly lower than those in the TWD+ group, 
at day 20 of pregnancy, but none of the values were different from baseline (Fig 3F) and the 
percentage of brain DHA and ARA did not differ in any of the groups (Supplemental Table 7).    
3.3 Fatty acid composition of the placenta and pup whole bodies. 
Placental DHA concentrations increased in all diets from day 15 to day 20 of pregnancy 
with the increase in the TWD+ placentas being significantly greater than the other diets (Fig 4A).  
While there was a tendency for total fatty acid concentrations to also increase from day 15 to day 
20 (approximately 30-40%), the percentages of DHA at day 20 remained significantly higher 
than day 15 for all the diets with TWD+ having the greatest increase (Supplemental Table 8).  
ARA concentrations did not differ in the placenta, but the percentages at day 20 decreased 
significantly in chow, and tended to be decreased in TWD.  In the fetus, whole body DHA 
concentrations did not differ (Fig 4B) although the percentage of DHA increased in the TWD+ 
and chow fetuses from day 15 to day 20 (Supplemental Table 9).  After birth, DHA 
concentrations increased in the pups relative to the fetuses in all the diets with a remarkable 
increase in the TWD+ diet (7 fold from baseline versus 3.7 fold in TWD- and 3.6 fold in chow, 
Fig 4B). After birth, total fatty acid concentrations increased significantly in all the pups with 
large increases in 18:2n-6, however, the concentrations in the TWD+ and TWD- 7 day old pup 
whole bodies were approximately 3 times the concentration of the chow-fed pups, which also 
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had increases in 18:1n-9 (Supplemental Table 9). The concentration of ARA in whole body pups 
was higher than the fetuses, while the percentages of ARA were lower.   
3.4 Fatty acid composition of pup brain, liver and heart. 
The pups from the TWD+ group had the highest concentrations of DHA all tissues, 
although chow had a statistically similar level of DHA in the heart (Fig. 5).  DHA concentrations 
in the brain and heart of TWD- group were also significantly lower than the chow group.  ARA 
concentrations were higher in heart with chow and in liver with TWD- and no differences in 
brain. Differences in total fatty acid concentrations appear to have contributed to this observation 
as total fatty acid concentrations in the TWD- group were lower in the brain and heart, but higher 
in the liver relative to the chow group (Supplemental Table 10).  In the brain, the percentage of 
DHA was only different (1.2 times higher) in the TWD+ group, while the percentages of 22:5n-6 
and 22:5n-3 were higher in the TWD- and chow pups as compared with the TWD+ pups 
(Supplemental Table 10).  The percentage of ARA in the brain of TWD- pups was higher than 
pups from the other diets.  In both the heart and liver, there were increases in the percentages of 
18:1n-9 with the TWD+ and TWD- feeding relative to chow.  In the heart, this was offset by 
lower percentages of 18:2n-6 and 18:3n-6 relative to chow, while in the liver, the TWD+ and 
TWD- had lower percentages of 18:0 and ARA (Supplemental Table 10). 
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4. Discussion 
Our results indicate that including preformed DHA can, in general, increase DHA status 
in various maternal, fetal and pup tissues even when fed a background Western style diet.  High 
fat feeding during pregnancy has been demonstrated to potentially reduce the hepatic DHA status 
of neonatal pups [33], but surprisingly, manipulating the DHA content of a Western style diet fed 
rodents during pregnancy has not been examined previously to our knowledge.  This is despite 
the fact that the use of DHA supplements during pregnancy is encouraged for women in Western 
countries [34].   
An increase in DHA concentrations in maternal plasma has been observed previously [3, 
6, 9, 14, 15, 35]. We also confirm a recent report that the DHA increase occurs largely in late and 
not early pregnancy, where it was demonstrated that DHA was specifically increased into 
palmitoyldocosahexaenoyl phosphatidylcholine for incorporation into lipoproteins during 
pregnancy induced hyperlipidemia [6]. In the present study, we demonstrate that the DHA 
increase in plasma during late pregnancy is even higher when preformed DHA is included in the 
diet, and that this metabolic adaptation to increase DHA in plasma for potential fetal uptake was 
also evident in the TWD- diet, a high fat diet without preformed DHA. The increase and 
decrease in DHA concentrations and percentages in plasma during pregnancy and postpartum 
have been observed previously in rodents [6] and in humans [3, 5].  This rise and fall is 
associated with changes in lipoprotein levels, but also DHA availability for incorporation into 
phosphatidylcholine [6, 36].  Erythrocyte DHA concentrations were also increased above 
baseline with this increase being higher and persisting into 7 days postpartum in the TWD+ 
group.  
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In the other maternal tissues examined, an increase in DHA concentrations at day 20 of 
pregnancy was observed only in tissues of the TWD+ group.  Specifically, liver, adipose, heart 
and erythrocyte, but not brain DHA concentrations were all increased above baseline at day 20 
and they all returned to baseline levels at 7 days postpartum.  In the heart and liver, the chow and 
TWD- groups were generally similar with the DHA concentrations remaining at baseline levels, 
but lower than the TWD+ group throughout pregnancy.  However, at 7 days postpartum, DHA 
concentrations fell below baseline levels in both the chow and TWD- groups in the heart, and in 
the TWD- group in the liver. The decrease in heart tissue DHA in both the chow and TWD- was 
not expected, but losses of DHA in the heart could have been anticipated. Heart tissue has a high 
concentration and percentage of DHA [16] and a high fatty acid turnover rate [37] with a 
potential specificity for lipolysis of long chain polyunsaturated fatty acid such as DHA [38, 39]. 
Fatty acid β-oxidation can provide 50-70% of the adult heart’s energy requirement, however this 
is under complex control [40].  Under certain conditions, including perfusion with insulin, 
cardiomyocytes can engage in reverse fatty acid transport [41].  Insulin levels are elevated during 
pregnancy [42].  It is possible that DHA could have been released from the heart to the 
circulation in the present study but additional studies are required to confirm.  
In contrast to the response in maternal liver and heart, perirenal adipose tissue DHA 
concentrations in the chow and TWD+ groups were similar, while the TWD- group was lower 
throughout pregnancy and postpartum.  The DHA content of adipose was actually increased at 
day 20 in the TWD+ and chow diets suggesting that adipose may have been taking up DHA from 
plasma, rather than providing it.  Previously it has been reported that DHA concentrations in 
periuterine decrease but that perirenal adipose do not change at 18 days of pregnancy [15].  We 
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observed the increase in DHA in perirenal adipose in the chow and TWD+ diets at day 20 but not 
day 15 of pregnancy.  
The lower levels of DHA in the adipose of the TWD- group throughout pregnancy and 
postpartum suggest that the fetal/pup requirements was not being met by the intake of dietary 
DHA and that adaptations to increase DHA biosynthesis during pregnancy [6, 43-45] could not 
meet the requirements as well.  The TWD- diet contained only 17 µg DHA/g diet (0.01% of total 
fat) while the chow diet had 226 µg DHA/g diet (0.41% of total fat). In regard to DHA 
biosynthesis, the total ALA content in the TWD- diet (3.17 mg ALA/g diet) was slightly higher 
than chow (2.63 mg ALA/g diet), but the % of ALA in total fat in the TWD- (1.8% of total fatty 
acids) was less than half of the chow diet (4.8% of total fatty acids).  Based on a previous study 
that considered the ratios of LA to ALA and the energy % of over 50 diets [46], it is unlikely that 
the DHA biosynthesis potential of the chow and TWD- diets would differ.  However, the 
previous work was completed in male rats and not pregnant females, and our study included 
different levels of preformed DHA in the diets.  In addition, high MUFA intakes can reduce 
ALA metabolism [21] and absolute MUFA content in the TWD- diet was 66.9 mg MUFA/g diet 
as compared with 13.4 mg MUFA/g diet in the chow diet.   
Placental and whole body pup DHA concentrations from our model are consistent with 
previous reports of maternal DHA status affecting fetal and infant DHA status through both 
placental transfer [12] and lactation [47].  The TWD+ pups had both higher whole body and 
tissue specific DHA concentrations when compared to their chow or TWD- counterparts. 
However, it was interesting that the differences in whole body DHA concentrations were only 
observed in the 7 day old pups and not in the fetuses. This suggests that maternal adaptations 
during pregnancy were meeting fetal accretion requirements, but that this did not extend into 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 17 
postpartum lactation.  Tissue fatty acid analyses of the pups indicate that while some of the 
increased DHA in the TWD+ group is probably excess and accumulating in depots such as liver 
and possibly adipose (not measured), diets low in DHA can result in slightly, but significantly 
lower levels in brain and heart.  Interestingly, the pup heart was the most sensitive to losses of 
DHA with the TWD- diet.  As mentioned previously, there is the potential for high DHA 
turnover in the heart, but it remains to be see if this turnover is to meet the metabolic need for 
DHA by the heart itself or if some of the DHA is released to the circulation for uptake by other 
tissues.  More research understanding DHA metabolism and turnover in the heart is needed.  The 
postpartum observations in this study may be unique to rodent models and not extrapolate to 
humans as rat pup brain development does not reach the same level as a term human infant until 
12 days postpartum [48]. In this rat model, however, it appears that while adaptations during 
pregnancy maintain maternal DHA status before birth, these adaptations change postpartum and 
may not support DHA physiological requirements by the pup via lactation.  
The changes in ARA levels differed from DHA.  With a standard rodent chow diet, the 
percentage of ARA has been shown to decrease in plasma phosphatidylcholine and liver 
phosphatidylcholine and phosphatidylethanolamine during pregnancy and it was speculated that 
fetal uptake of ARA may be met through transfer of ARA from abundant maternal tissue stores 
rather than new synthesis [6].  The present study appears to confirm this response in the chow 
rats as well as the TWD diets and ARA tended to decrease or remain the same in plasma and 
liver. ARA and DHA in adipose, heart and brain did have relatively similar responses throughout 
pregnancy, but DHA tended to increase in placenta while ARA decreased.  In the fetuses/pups, 
the percentage of ARA tended to decrease slightly during pregnancy followed by a large 
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decrease postpartum especially in the TWD diets.  In contrast, DHA percentages increased in 
fetal whole bodies at day 20 of pregnancy and then decreased postpartum.    
This study has several limitations.  Maternal DHA status was examined by manipulating 
the DHA content of the TWD diet that is designed to mimic the human diet of Americans.  The 
TWD has higher fat content but also differences in sucrose and fiber as well as micronutrients 
when compared to the rodent chow.  We included a natural ingredient chow diet with most of the 
fat provided by soybean oil to allow for crude comparison to the existing literature that is 
predominantly based on rodent chow recommendations. However, it appears that low fat diets 
that reflect human fat consumption while controlling for micronutrient content should be 
considered in future studies.  While we screened several maternal and fetal/pup tissues across 
various time points to identify decreases in tissue levels as evidence of maternal mobilization of 
DHA for fetal/pup transfer, only static measures of tissue fatty acid levels were completed.  Also, 
while we did examine several maternal tissues, our own results of decreases in DHA in heart 
indicate that maternal skeletal muscle should also be examined, and a recent study suggests that 
other adipose sites should be examined as well [15]. We hope that the present findings can guide 
targeted kinetic studies using fatty acid tracers to assess true DHA mobilization in the future. 
While our use of a background diet that resembled human fat intakes was novel for DHA 
supplementation during pregnancy, there were some unanticipated results that made it difficult to 
compare to the existing literature in the field. The TWD+ and TWD- resulted in significant 
increases in hepatic total fatty acids at postpartum only (73.1 ± 25.4 and 77.2 ± 33.3 mg/g) that 
suggested progression towards fatty liver.  Total hepatic fatty acid concentrations of 122 mg/g 
and percentage shifts towards higher 18:1n-9 and lower 18:0 has been observed previously in 
rats with steatosis [49].  This was not present during pregnancy, and was not reflected in 
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maternal adipose, but it was reflected in the pup whole body total fatty acids. As we only 
measured one postpartum time point, the duration of this response and the consequences of these 
diets on maternal and pup health need to be examined in more detail.  
In conclusion, we provide further evidence that DHA is increased in plasma during late 
pregnancy across diets with different intakes of DHA and that tissues other than adipose and 
liver may be a source of DHA during pregnancy and lactation in order to meet fetal and pup 
accretion and physiological requirements. Our observations also suggest that in this model, 
maternal adaptations to meet lipid and fatty acid requirements change in the transition from 
pregnancy to lactation with the pup requirement for DHA during lactation being particularly 
detrimental to maternal tissue levels when dietary DHA levels are low. Additional work 
examining the rates of mobilization of DHA from maternal tissues, and the dietary intake 
required to prevent tissue decreases, could help define dietary requirements during pregnancy.  
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Table 1  
Nutrient and fatty acid composition of chow versus DHA supplemented (TWD+) and 
unsupplemented (TWD-) Total Western Diets. 
Diet component Chow TWD+ TWD- 
Energy Density (kcal/g) 4.4 4.4 3.0 
Macronutrients (g/100g)    
Protein 22.0 16.8 16.8 
Carbohydrate 40.6 54.6 54.6 
Fat 5.5 16.7 16.7 
Fatty Acid (weight %) 
 
  
16:0 13.24 ± 0.11 18.73 ± 0.08 18.81 ± 0.13 
18:0 3.68 ± 0.02 8.87 ± 0.01 9.16 ± 0.01 
Total SFA 18.56 ± 0.13 32.78 ± 0.05 32.74 ± 0.16 
16:1 0.77 ± 0.01 1.18 ± 0.01 1.14 ± 0.01 
18:1n-7 1.31 ± 0.01 1.49 ± 0.02 1.52 ± 0.06 
18:1n-9 21.82 ± 0.26 36.64 ± 0.10 36.79 ± 0.08 
Total MUFA 24.34 ± 0.23 39.90 ± 0.10 40.03 ± 0.07 
18:2n-6 48.51 ± 0.05 20.21 ± 0.04 20.86 ± 0.03 
20:4n-6 0.14 ± 0.02 0.08 ± 0.01 0.09 ± 0.01 
Total n-6 PUFA 48.82 ± 0.03 20.55 ± 0.04 21.23 ± 0.05 
18:3n-3 4.78 ± 0.01 1.83 ± 0.01 1.90 ± 0.01 
20:3n-3 0.01 ± 0.01 0.02 ± 0.01 0.02 ± 0.01 
20:5n-3 0.42 ± 0.01 0.01 ± 0.01 0.01 ± 0.01 
22:5n-3 0.08 ± 0.01 0.05 ± 0.01 0.03 ± 0.01 
22:6n-3 0.41 ± 0.02 1.21 ± 0.02 0.01 ± 0.01 
Total n-3 PUFA 5.71 ± 0.03 3.12 ± 0.01 1.98 ± 0.01 
Data for fatty acid composition (% wt) is mean ± SD from triplicate analysis in our laboratory. 
SFA: saturated fatty acids, MUFA: monounsaturated fatty acids, PUFA: polyunsaturated fatty 
acids.  
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Fig 1. Study design flowchart. Female Sprague Dawley rats were fed either a fixed formula 8640 
Teklad 22/5 Rodent Diet (Chow), a TD.110424 total western diet with DHA (TWD+) or a total 
western diet without DHA (TWD-).  Baseline rats were sacrificed at 9 weeks of age after one 
week on the diets. Rats assigned to the pregnancy groups were fed chow diets until confirmation 
of pregnancy and then immediately assigned to one of the 3 diets, and sacrificed at 15d of 
pregnancy, 20d of pregnancy or 7d postpartum (n=6 for each group). 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 27 
 
Fig. 2. Food intake across pregnancy and postpartum. *Significantly higher than intakes at other 
time points for all diets (main effect of time by two-way ANOVA followed by Tukey post hoc 
(p<0.05). Mean ± SD, n = 6 for each point. 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 28 
 
 
 
Fig. 3. Effects of pregnancy and diet on DHA concentrations of maternal tissues. Adipose is 
white perirenal adipose tissue. Different letters indicate diet differences within a time point, and 
* indicate differences within a diet from baseline. All differences were determined by Tukey’s 
post hoc following significant F-value by two-way ANOVA (p<0.05). Mean ± SD, n = 6 for 
each point.  
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Fig. 4. Effects of pregnancy and diet on placental, and whole body fetus/pup DHA 
concentrations. Different letters indicate diet differences within a time point, and * indicate 
within diet differences from baseline. All differences are as determined by Tukey’s post hoc 
following significant F-value by two-way ANOVA (p<0.05). Mean ± SD, n = 6 for each point. 
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Fig. 5. Effect of maternal diet on DHA concentrations of brain, heart, and liver of 7-day old 
pups. Different letters indicate differences between diets as determined by Tukey’s post hoc 
following significant F-value by one-way ANOVA (p<0.05). 
